Gene · 25833
Papers1,618
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,618
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcription factor-based subtype assignment in pulmonary large cell neuroendocrine carcinoma. | Histopathology | 2026 | 41293870 | PubTator, text mining | PubMed |
| Differentiating well-differentiated neuroendocrine tumors grade 3 from poorly differentiated neuroendocrine carcinomas and adenocarcinoma with neuroendocrine differentiation: a comprehensive review. | Virchows Arch | 2026 | 41276674 | PubTator, text mining | PubMed |
| Molecular Subtypes of Neuroendocrine Carcinoma: From Chaos to Consensus. | Annu Rev Pathol | 2026 | 41061171 | PubTator, text mining | PubMed |
| Prognostic utility of baseline ASCL1/INSM1 expression and neutrophil-lymphocyte ratio in unresectable SCLC treated with first-line chemoimmunotherapy with or without radiotherapy. | Front Med | 2025 | 41454081 | PubTator, text mining | PubMed |
| CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level. | bioRxiv | 2025 | 41446220 | PubTator, text mining | PubMed |
| Tuft cell-mediated pathogen sensing and inflammation resolution. | Biochem Soc Trans | 2025 | 41288617 | PubTator, text mining | PubMed |
| Bridging Knowledge Gaps in Small Cell Lung Cancer: Data, Challenges and Priorities. | Curr Oncol | 2025 | 41149456 | PubTator, text mining | PubMed |
| Expression of YAP1 delineates distinct subtypes of pulmonary large cell neuroendocrine carcinoma with divergent therapeutic implications. | Transl Lung Cancer Res | 2025 | 41132957 | PubTator, text mining | PubMed |
| Tumor Heterogeneity and Plasticity in Small Cell Lung Cancer. | Lung Cancer (Auckl) | 2025 | 41098578 | PubTator, text mining | PubMed |
| Emerging Therapeutic Strategies for Lung Cancer: The Role of Immunotherapy and HPV-Targeted Cancer Vaccines. | Vaccines (Basel) | 2025 | 41012160 | PubTator, text mining | PubMed |
| Diminished Admission to Skilled Nursing Facility Following the Use of Direct Anterior Approach for Treating Femoral Neck Fractures in a Geriatric Population. | J Orthop Trauma | 2025 | 40970705 | PubTator, text mining | PubMed |
| Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer. | Nature | 2025 | 40963028 | PubTator, text mining | PubMed |
| Learning the cellular origins across cancers using single-cell chromatin landscapes. | Nat Commun | 2025 | 40962882 | PubTator, text mining | PubMed |
| Prognostic values and clinical significance of POU2F3 expression in neuroendocrine carcinomas: a meta-analysis with a focus on small cell lung cancer. | Ann Med | 2025 | 40931642 | PubTator, text mining | PubMed |
Comprehensive Analysis of Neurogenic Differentiation Factor 1 (NEUROD1), Achaete-Scute Homolog 1 (ASCL1), POU Class 2 Homeobox 3 (POU2F3), and Yes-Associated Protein 1 (YAP1) Expression Signatures Reveals Unique Large-Cell Neuroendocrine Carcinoma (LCNEC) Subgroups With Potential Therapeutic Implications. | Lab Invest | 2025 | 40902984 | PubTator, text mining | PubMed |
| Deep learning-based histomorphological subtyping and risk stratification of small cell lung cancer from hematoxylin and eosin-stained whole slide images. | Genome Med | 2025 | 40898302 | PubTator, text mining | PubMed |
| Molecular Characteristics, Heterogeneity, Plasticity, and Cell of Origin of Neuroendocrine Bladder Cancer. | Cancer Heterog Plast | 2025 | 40893664 | PubTator, text mining | PubMed |
| Lineage-specific transcription factor landscape of thymic neuroendocrine tumors. | Lung Cancer | 2025 | 40884897 | PubTator, text mining | PubMed |
| Immunohistochemical Demonstration of Tuft Cells in Human Acinar-to-Ductal Metaplasia and Pancreatic Intraepithelial Neoplasia. | Biomedicines | 2025 | 40868198 | PubTator, text mining | PubMed |
| Immunoinformatics Design and Identification of B-Cell Epitopes from Vespa affinis PLA1 Allergen. | Toxins (Basel) | 2025 | 40864049 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25833/papers?page=5